Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease

Overview

Journal J Vet Intern Med

Specialties General Medicine
Veterinary Medicine

Date 2016 May 8

PMID 27155206

Citations 4

Authors

T L Williams

H Dillon

J Elliott

H M Syme

J Archer

Affiliations

Soon will be listed here.

Abstract

Background: Currently, no test can accurately predict the development of azotemia after treatment of hyperthyroidism. Serum cystatin C concentrations (sCysC) might be less influenced by changes in body muscle mass and so better indicate the presence of concurrent chronic kidney disease (CKD) in hyperthyroidism.

Hypotheses: sCysC will be higher in hyperthyroid cats that develop azotemia compared with hyperthyroid cats that remain nonazotemic after treatment; sCysC will be higher in nonhyperthyroid cats with azotemic CKD than healthy older cats and, sCysC will decrease after treatment of hyperthyroidism.

Animals: Ninety-one cats treated in first opinion practice.

Methods: Case-control study. sCysC were compared between hyperthyroid cats which developed azotemia within 4 months of successful treatment of hyperthyroidism (pre-azotemic group) and hyperthyroid cats which remained nonazotemic after treatment (nonazotemic group), and between nonhyperthyroid cats with azotemic CKD and healthy older cats. sCysC were also compared between hyperthyroid cats before treatment and at time of establishment of euthyroidism. Data are presented as median [25th, 75th percentile].

Results: Baseline sCysC were not different between the pre-azotemic and nonazotemic groups (1.9 [1.4, 2.3] mg/L versus 1.5 [1.1, 2.2] mg/L, respectively; P = .22). sCysC in nonhyperthyroid cats with azotemic CKD and healthy older cats were not significantly different (1.5 [1.0, 1.9] mg/L versus 1.2 [0.8, 1.4] mg/L, respectively; P = .16). sCysC did not change significantly after treatment of hyperthyroidism (pretreatment 1.8 [1.2, 2.3] mg/L, after treatment 1.6 [1.1, 2.4] mg/L; P = .82).

Conclusions And Clinical Importance: sCysC do not appear to be a reliable marker of renal function in hyperthyroid cats.

Citing Articles

Comparison of Three Different Diagnostic Assays for Fibroblast Growth Factor-23 (FGF-23) Measurements in Cats: A Pilot Study.

Lapsina S, Nagler N, Muller S, Holtdirk A, Kottmann T, Muller E Animals (Basel). 2023; 13(11).

PMID: 37889764 PMC: 10251965. DOI: 10.3390/ani13111853.

Renal biomarkers in cats: A review of the current status in chronic kidney disease.

Kongtasai T, Paepe D, Meyer E, Mortier F, Marynissen S, Stammeleer L J Vet Intern Med. 2022; 36(2):379-396.

PMID: 35218249 PMC: 8965260. DOI: 10.1111/jvim.16377.

Assessment of the association between diabetes mellitus and chronic kidney disease in adult cats.

Perez-Lopez L, Boronat M, Melian C, Saavedra P, Brito-Casillas Y, Wagner A J Vet Intern Med. 2019; 33(5):1921-1925.

PMID: 31305000 PMC: 6766521. DOI: 10.1111/jvim.15559.

Changes in thyroid and renal function after bilateral thyroidectomy in cats.

Covey H, Chang Y, Elliott J, Syme H J Vet Intern Med. 2019; 33(2):508-515.

PMID: 30758070 PMC: 6430951. DOI: 10.1111/jvim.15450.

References

Shiel R, Mooney C . Testing for hyperthyroidism in cats. Vet Clin North Am Small Anim Pract. 2007; 37(4):671-91, vi. DOI: 10.1016/j.cvsm.2007.03.006. View

Ghys L, Paepe D, Duchateau L, Taffin E, Marynissen S, Delanghe J . Biological validation of feline serum cystatin C: The effect of breed, age and sex and establishment of a reference interval. Vet J. 2015; 204(2):168-73. DOI: 10.1016/j.tvjl.2015.02.018. View

Armbruster D, Pry T . Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008; 29 Suppl 1:S49-52. PMC: 2556583. View

den Hollander J, Wulkan R, Mantel M, Berghout A . Is cystatin C a marker of glomerular filtration rate in thyroid dysfunction?. Clin Chem. 2003; 49(9):1558-9. DOI: 10.1373/49.9.1558. View

Williams T, Archer J . Validation of an automated enzyme immunoassay for the measurement of serum total thyroxine in cats. Vet Clin Pathol. 2016; 45(1):148-53. DOI: 10.1111/vcp.12324. View

Ghys L, Paepe D, Lefebvre H, Taffin E, Hesta M, Delanghe J . The effect of feeding, storage and anticoagulant on feline serum cystatin C. Vet J. 2015; 206(1):91-6. DOI: 10.1016/j.tvjl.2015.07.001. View

van Hoek I, Lefebvre H, Peremans K, Meyer E, Croubels S, Vandermeulen E . Short- and long-term follow-up of glomerular and tubular renal markers of kidney function in hyperthyroid cats after treatment with radioiodine. Domest Anim Endocrinol. 2008; 36(1):45-56. DOI: 10.1016/j.domaniend.2008.10.001. View

Riensche M, Graves T, Schaeffer D . An investigation of predictors of renal insufficiency following treatment of hyperthyroidism in cats. J Feline Med Surg. 2007; 10(2):160-6. PMC: 10911216. DOI: 10.1016/j.jfms.2007.10.005. View

Williams T, Elliott J, Syme H . Association of iatrogenic hypothyroidism with azotemia and reduced survival time in cats treated for hyperthyroidism. J Vet Intern Med. 2010; 24(5):1086-92. DOI: 10.1111/j.1939-1676.2010.0566.x. View

10.

Williams T, Archer J . Evaluation of urinary biomarkers for azotaemic chronic kidney disease in cats. J Small Anim Pract. 2015; 57(3):122-9. DOI: 10.1111/jsap.12439. View

11.

Ghys L, Meyer E, Paepe D, Delanghe J, Daminet S . Analytical validation of a human particle-enhanced nephelometric assay for cystatin C measurement in feline serum and urine. Vet Clin Pathol. 2014; 43(2):226-34. DOI: 10.1111/vcp.12144. View

12.

Adams W, Daniel G, Legendre A . Investigation of the effects of hyperthyroidism on renal function in the cat. Can J Vet Res. 1997; 61(1):53-6. PMC: 1189370. View

13.

Adams W, Daniel G, Legendre A, Gompf R, Grove C . Changes in renal function in cats following treatment of hyperthyroidism using 131I. Vet Radiol Ultrasound. 1997; 38(3):231-8. DOI: 10.1111/j.1740-8261.1997.tb00846.x. View

14.

Ghys L, Paepe D, Lefebvre H, Reynolds B, Croubels S, Meyer E . Evaluation of Cystatin C for the Detection of Chronic Kidney Disease in Cats. J Vet Intern Med. 2016; 30(4):1074-82. PMC: 5108422. DOI: 10.1111/jvim.14256. View

15.

Uchida K, Gotoh A . Measurement of cystatin-C and creatinine in urine. Clin Chim Acta. 2002; 323(1-2):121-8. DOI: 10.1016/s0009-8981(02)00177-8. View

16.

van Hoek I, Meyer E, Duchateau L, Peremans K, Smets P, Daminet S . Retinol-binding protein in serum and urine of hyperthyroid cats before and after treatment with radioiodine. J Vet Intern Med. 2009; 23(5):1031-7. DOI: 10.1111/j.1939-1676.2009.0364.x. View

17.

Hall J, Obare E, Yerramilli M, Jewell D . Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease. J Vet Intern Med. 2014; 28(6):1676-83. PMC: 4895610. DOI: 10.1111/jvim.12445. View

18.

Boag A, Neiger R, Slater L, Stevens K, Haller M, Church D . Changes in the glomerular filtration rate of 27 cats with hyperthyroidism after treatment with radioactive iodine. Vet Rec. 2007; 161(21):711-5. DOI: 10.1136/vr.161.21.711. View

19.

Ghys L, Paepe D, Taffin E, Vandermeulen E, Duchateau L, Smets P . Serum and urinary cystatin C in cats with feline immunodeficiency virus infection and cats with hyperthyroidism. J Feline Med Surg. 2015; 18(8):658-65. PMC: 10816382. DOI: 10.1177/1098612X15592343. View

20.

Lapointe C, Belanger M, Dunn M, Moreau M, Bedard C . N-acetyl-beta-D-glucosaminidase index as an early biomarker for chronic kidney disease in cats with hyperthyroidism. J Vet Intern Med. 2008; 22(5):1103-10. DOI: 10.1111/j.1939-1676.2008.0168.x. View